Show simple item record

Identifying the clinical domains of fibromyalgia: Contributions from clinician and patient delphi exercises

dc.contributor.authorMease, Philip J.en_US
dc.contributor.authorArnold, Lesley M.en_US
dc.contributor.authorCrofford, Leslie J.en_US
dc.contributor.authorWilliams, David A.en_US
dc.contributor.authorRussell, I. Jonen_US
dc.contributor.authorHumphrey, Louiseen_US
dc.contributor.authorAbetz, Lindaen_US
dc.contributor.authorMartin, Susan A.en_US
dc.date.accessioned2008-08-04T15:13:38Z
dc.date.available2009-08-12T18:32:18Zen_US
dc.date.issued2008-07-15en_US
dc.identifier.citationMease, Phillip J.; Arnold, Lesley M.; Crofford, Leslie J.; Williams, David A.; Russell, I. Jon; Humphrey, Louise; Abetz, Linda; Martin, Susan A. (2008). "Identifying the clinical domains of fibromyalgia: Contributions from clinician and patient delphi exercises." Arthritis & Rheumatism 59(7): 952-960. <http://hdl.handle.net/2027.42/60452>en_US
dc.identifier.issn0004-3591en_US
dc.identifier.issn1529-0131en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/60452
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18576290&dopt=citationen_US
dc.description.abstractObjective In evaluating the effectiveness of fibromyalgia (FM) therapies, it is important to assess the impact of those therapies on the full array of domains considered important by both clinicians and patients. The objective of this research was to identify and prioritize the key clinically relevant and important domains impacted by FM that should be evaluated by outcome assessment instruments used in FM clinical trials, and to approach consensus among clinicians and patients on the priority of those domains to be assessed in clinical care and research. Methods Group consensus was achieved using the Delphi method, a structured process of consensus building via questionnaires together with systematic and controlled opinion feedback. The Delphi exercises involved 23 clinicians with expertise in FM and 100 patients with FM as defined by American College of Rheumatology criteria. Results The Delphi exercise revealed that the domains ranked most highly by patients were similar to the domain rankings by clinicians. Pain was consistently ranked highest by both panels. Fatigue, impact on sleep, health-related quality of life, comorbid depression, and cognitive difficulty were also ranked highly. Stiffness was ranked highly by patients but not clinicians. In contrast, side effects was important to clinicians but was not identified as important in the patient Delphi exercise. Conclusion The clinician and patient Delphi exercises identified and ranked key domains that need to be assessed in FM research. Based on these results, a conceptual framework for measuring patient-reported outcomes is proposed.en_US
dc.format.extent111577 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.titleIdentifying the clinical domains of fibromyalgia: Contributions from clinician and patient delphi exercisesen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeriatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan, Ann Arbor ; Dr. Williams has received consultant fees (less than $10,000 each) from Eli Lilly, Cypress Biosciences, Forest, and Pierre Fabre.en_US
dc.contributor.affiliationotherSeattle Rheumatology Associates, Seattle, Washington ; Dr. Mease has received consultant fees and grant/research support (less than $10,000 each) from Pfizer, Cypress Biosciences, Forest, Eli Lilly, Allergan, Fralex, Boehringer-Ingelheim, Jazz, Wyeth, and Pierre Fabre, and has received speaking fees (less than $10,000) from Pfizer. ; Seattle Rheumatology Associates, 1101 Madison Street, Suite 1000, Seattle, WA 98104en_US
dc.contributor.affiliationotherUniversity of Cincinnati, Cincinnati, Ohio ; Dr. Arnold has received consultant fees, speaking fees, and/or grant/research support (less than $10,000 each) from Cypress Bio sciences, Boehringer-Ingelheim, Forest, Allergan, Organon, Sanofi-Aventis, Sepracor, and Vivus, and (more than $10,000 each) from Eli Lilly, Pfizer, and Wyeth.en_US
dc.contributor.affiliationotherUniversity of Kentucky, Lexington ; Dr. Crofford has received consultant fees and/or grant/research support (less than $10,000 each) from Pfizer, Eli Lilly, Allergan, and Wyeth.en_US
dc.contributor.affiliationotherUniversity of Texas, San Antonio ; Dr. Russell has received consultant fees, speaking fees, and/or honoraria (less than $10,000) from Lilly and (more than $10,000 each) from Pfizer and Jazz.en_US
dc.contributor.affiliationotherMapi Values, Bollington, UK ; Ms Humphrey and Ms Abetz received research/grant support from Pfizer and were contracted by Pfizer to assist in the present study.en_US
dc.contributor.affiliationotherMapi Values, Bollington, UKen_US
dc.contributor.affiliationotherPfizer, Ann Arbor, Michigan ; Ms Martin owns stock in Pfizer.en_US
dc.identifier.pmid18576290en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/60452/1/23826_ftp.pdf
dc.identifier.doihttp://dx.doi.org/10.1002/art.23826en_US
dc.identifier.sourceArthritis & Rheumatismen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.